These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7107047)

  • 41. The significance of oxalate in renal failure.
    Thompson CS; Weinman EJ
    Am J Kidney Dis; 1984 Sep; 4(2):97-100. PubMed ID: 6475952
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amelioration of uremic tumoral calcinosis with high-flux hemodialysis treatment.
    Xie T; Zhang Y; Tang X; Chen M; Zhang W
    Int Urol Nephrol; 2014 Jul; 46(7):1467-8. PubMed ID: 24595601
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful treatment of soft tissue calcifications in uremia.
    Sikole A; Stojkovski L; Cakalaroski K; Stojcev N; Amitov V; Polenakovic M
    Prilozi; 2006 Jul; 27(1):145-50. PubMed ID: 16985488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
    Rolton HA; McConnell KM; Modi KS; Macdougall AI
    Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended hemodialysis in children with chronic renal failure.
    Fine RN; De Palma JR; Lieberman E; Donnell GN; Gordon A; Maxwell MH
    J Pediatr; 1968 Nov; 73(5):706-13. PubMed ID: 4300674
    [No Abstract]   [Full Text] [Related]  

  • 47. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
    Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
    Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure.
    Mousson C; Justrabo E; Rifle G; Sgro C; Chalopin JM; Gérard C
    Nephron; 1993; 63(1):104-6. PubMed ID: 8446234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning].
    Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB
    Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752
    [No Abstract]   [Full Text] [Related]  

  • 50. [Periaticular metastatic calcifications in uremic patients].
    Fabbri L; Fusaroli M; Catizone L; Zucchelli P
    Minerva Med; 1975 Jan; 66(5):209-19. PubMed ID: 1113921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anemia of chronic renal failure: studies of marrow regulation in the uremic sheep.
    Eschbach JW; Adamson JW; Anderson RG; Dennis MB
    Trans Am Soc Artif Intern Organs; 1972; 18(0):295-300. PubMed ID: 4681673
    [No Abstract]   [Full Text] [Related]  

  • 52. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease.
    Hoffman GS; Schumacher HR; Paul H; Cherian V; Reed R; Ramsay AG; Franck WA
    Ann Intern Med; 1982 Jul; 97(1):36-42. PubMed ID: 7092004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated plasma adenine nucleotide levels in chronic renal failure and their possible significance.
    Moss AH; Solomons CC; Alfrey AC
    Proc Clin Dial Transplant Forum; 1979; 9():184-8. PubMed ID: 399505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ion chromatographic determination of plasma oxalate in healthy subjects, in patients with chronic renal failure and in cases of hyperoxaluric syndromes.
    Petrarulo M; Bianco O; Marangella M; Pellegrino S; Linari F; Mentasti E
    J Chromatogr; 1990 Jul; 511():223-31. PubMed ID: 2211912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Chen T; Cleland B; Nankivell BJ
    Kidney Int; 2016 Jun; 89(6):1409-10. PubMed ID: 27181789
    [No Abstract]   [Full Text] [Related]  

  • 56. Major factors modulating the serum oxalic acid level in hemodialysis patients.
    Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
    Obad D; Larsen NA; Pedersen EB
    Ugeskr Laeger; 2010 Mar; 172(9):719-21. PubMed ID: 20199755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chen TW; Lee YH; Chu WY; Young TK
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
    Hsu SC; Lee YY; Wang MC; Liu HL; Cheng MF; Huang JJ
    Blood Purif; 2004; 22(2):224-8. PubMed ID: 15044822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.